Unlike PD-L1, PD-1 Is Downregulated on Partial Immune Cells in Type 2 Diabetes
Introduction. Type 2 diabetes is a worldwide disease which is associated with chronic, low-grade inflammation. The PD-1/PD-L1 pathway has been reported to be a negative regulatory element in immune homeostasis and to be involved in many diseases. Materials and Methods. Peripheral blood mononuclear c...
Main Authors: | Peng Sun, Qingyan Jin, Shengnan Nie, Shijie Jia, Yuanyuan Li, Xiaoxue Li, Fang Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/5035261 |
Similar Items
-
Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis
by: Mohammad Reza Javan, et al.
Published: (2016-08-01) -
Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility
by: Chenyue Qian, et al.
Published: (2018-01-01) -
Downregulation of the PD-1/PD-Ls pathway in peripheral cells correlates with asbestosis severity
by: Meihua Qiu, et al.
Published: (2021-05-01) -
Peripheral blood T lymphocytes are downregulated by the PD-1/PD-L1 axis in advanced gastric cancer
by: Witold Zgodzinski, et al.
Published: (2018-04-01) -
PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
by: Michal Šmahel
Published: (2017-06-01)